Nobelpharma America, LLC Email Format

Pharmaceutical ManufacturingMaryland, United States11-50 Employees

Nobelpharma America, LLC operates in the pharmaceutical manufacturing sector, developing medicines and medical devices with a focus on underserved patient populations and undertreated conditions. Based in Bethesda, Maryland, the company maintains a small to mid-sized team and targets solutions for patients affected by rare diseases. Beyond product development, Nobelpharma has established initiatives to support access and education, including Nobelpharma Connect, a patient hub for eligibility and enrollment in assistance and copay programs, and FACE FORWARD, an educational site about facial angiofibroma linked to tuberous sclerosis complex.

In March 2023, Nobelpharma America launched its first pharmaceutical product into the U.S. rare diseases marketplace. The company has marketed Hyftor, a 0.2% sirolimus topical gel for facial angiofibroma associated with tuberous sclerosis complex in patients aged 6 years and older, described in its news as the first FDA-approved topical treatment for this condition. The overall focus is on serving underserved patient groups by combining product development with patient access and education resources within the pharmaceutical industry.

Sign up for free to view info

Company overview Employee directory